DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG: Fritz Oesterle reinforces Eckert & Ziegler Supervisory Board

DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key
word(s): Change of Personnel/Miscellaneous
Eckert & Ziegler Strahlen- und Medizintechnik AG: Fritz Oesterle
reinforces Eckert & Ziegler Supervisory Board

14.12.2011 / 10:42

---------------------------------------------------------------------

Berlin, 14 December 2011. The lawyer and long-term former CEO of
MDAX-listed Celesio AG, Dr. Fritz Oesterle (59), will reinforce the
Supervisory Board of Eckert & Ziegler Strahlen- und Medizintechnik AG from
January 2012. He replaces the fund manager, Holger Bürk, who will lay down
his mandate as of 31 December 2011 after a three-year period of office as
the expectations associated with his entry into the Supervisory Board 'were
more than satisfied'. A direct exchange of both Supervisory Board members
is possible as according to the statutes the founders of Eckert & Ziegler
AG are entitled to delegate a member of the Supervisory Board.

'I would like to thank Mr Bürk for the trustworthy cooperation and his many
years of work. Due to his associations with the financial markets he was a
valuable supplement to our body, in particular following the turbulences on
the capital markets which began during the course of the Lehman-Brothers
crisis. I am now pleased with Dr. Oesterle to be able to welcome a
distinguished expert from the health sector. He will help us to continue to
press ahead with the orientation of Eckert & Ziegler AG to
radiopharmaceuticals which record strong growth', Dr. Andreas Eckert, CEO
of Eckert & Ziegler AG, declared.

Dr. Fritz Oesterle is a lawyer and, inter alia, a member of the supervisory
board of Landesbank Baden-Wuerttemberg and of Schwarz Unternehmenstreuhand
(Kaufland, Lidl). He was previously CEO of Celesio AG for twelve years. Dr.
Oesterle is also a member of various bodies, to include the health
committee of the German Chamber of Commerce (DIHK), Berlin, the health
committee of the Economic Affairs Council [Wirtschaftsrat] Germany, and the
advisory board of Société Générale in Germany. Besides, Dr. Oesterle is the
British Honorary Consul in Baden-Wuerttemberg.

With around 580 employees the Eckert & Ziegler Group (ISIN DE0005659700) is
among the largest providers of isotope components for radiation therapy and
nuclear medicine worldwide.

If you have any questions please contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.de


End of Corporate News

---------------------------------------------------------------------

14.12.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English                                                      
Company:     Eckert & Ziegler Strahlen- und Medizintechnik AG             
             Robert-Rössle-Str.10                                         
             13125 Berlin                                                 
             Germany                                                      
Phone:       49 30 941084-138                                             
Fax:         49 30 941084-112                                             
E-mail:      karolin.riehle@ezag.de                                       
Internet:    www.ezag.de                                                  
ISIN:        DE0005659700                                                 
WKN:         565970                                                       
Listed:      Regulierter Markt in Frankfurt (Prime Standard), Stuttgart;  
             Freiverkehr in Berlin, Düsseldorf, Hamburg, München          
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
149689 14.12.2011